미국의 페리틴 검사 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 수법별, 검사 유형별, 최종 용도별, 부문별 예측(2025-2033년)

U.S. Ferritin Testing Market Size & Trends:

The U.S. ferritin testing market size was estimated at USD 274.60 million in 2024 and is projected to grow at a CAGR of 5.63% from 2025 to 2033. The market is driven by the rising prevalence of iron deficiency anemia and related chronic conditions such as inflammatory diseases, chronic kidney disease, and cancer.

Increasing awareness among healthcare professionals about the importance of ferritin as a biomarker for iron storage and inflammation has led to its growing adoption in both routine health screenings and specialized diagnostic protocols. In addition, the expanding geriatric population is more susceptible to anemia and nutritional deficiencies has amplified the demand for ferritin testing in clinical settings.

Millions of women of childbearing age and young children under five are likely suffering from anemia, experiencing symptoms like fatigue, weakness, and shortness of breath. These debilitating effects not only diminish their health and productivity but also have a broader impact on families, communities, and the development of nations. The chart below illustrates the incidence of anemia in the U.S. from 2021 to 2023.

U.S. Ferritin Testing Market Report Segmentation

This report forecasts revenue growth at, regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. ferritin testing market report based on product, application, technique, test type, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instrument
• Reagent
• Kits
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Anemia
• Hemochromatosis
• Lead Poisoning
• Pregnancy
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostic Laboratories

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Ferritin Testing Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
    • 3.3.1.1. Rising Prevalence of Iron-Deficiency Anemia
    • 3.3.1.2. Increased Adoption of Preventive Health Screenings
    • 3.3.1.3. Advancements in Point-of-Care and At-Home Testing Kits
  • 3.3.2. Market Restraints Analysis
    • 3.3.2.1. Stringent Regulations
  • 3.3.3. Market Opportunities Analysis
  • 3.3.4. Market Challenges Analysis
    • 3.3.4.1. Product Recalls
• 3.4. U.S. Ferritin Testing Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. U.S. Ferritin Testing Market: Product Estimates & Trend Analysis

• 4.1. U.S. Ferritin Testing Market: Product Movement Analysis
• 4.2. U.S. Ferritin Testing Market Estimates and Forecasts, by Product (USD Million), 2024 & 2033
• 4.3. Kits
  • 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Reagents
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Instrument
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Ferritin Testing Market: Application Estimates & Trend Analysis

• 5.1. U.S. Ferritin Testing Market: Application Movement Analysis
• 5.2. U.S. Ferritin Testing Market Estimates and Forecasts, by Application (USD Million), 2024 & 2033
• 5.3. Anemia
  • 5.3.1. Anemia Market, 2021 - 2033 (USD Million)
• 5.4. Hemochromatosis
  • 5.4.1. Hemochromatosis Market, 2021 - 2033 (USD Million)
• 5.5. Lead Poisoning
  • 5.5.1. Lead Poisoning Market, 2021 - 2033 (USD Million)
• 5.6. Pregnancy
  • 5.6.1. Pregnancy Market, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. U.S. Ferritin Testing Market: End Use Estimates & Trend Analysis

• 6.1. U.S. Ferritin Testing Market: End-use Movement Analysis
• 6.2. U.S. Ferritin Testing Market Estimates and Forecasts, by End-use (USD Million), 2024 & 2033
• 6.3. Hospitals
  • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
• 7.5. Company Profiles/Listing
  • 7.5.1. Eurolyser Diagnostica GmbH
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Collection Site Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Cortez Diagnostics Inc
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Collection Site Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Pointe Scientific, Inc
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Collection Site Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Aviva Systems Biology Corporation
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Collection Site Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. bioMerieux S.A
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Collection Site Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Abnova Corporation
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Collection Site Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. CTK Biotech, Inc
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Collection Site Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Thermo Fisher Scientific Inc.
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Collection Site Benchmarking
    • 7.5.8.4. Strategic Initiatives